Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Beneficient (NASDAQ:BENF) reported quarterly sales of $10.00 million which beat the analyst consensus estimate of $1.68 million by 23.64 percent. This is a 31.01 percent decrease over sales of $1.85 million the same period last year.
Posted In: BENF